New radiation approach aims to control prostate cancer in fewer sessions
NCT ID NCT04147806
First seen Apr 14, 2026 · Last updated May 16, 2026 · Updated 5 times
Summary
This early-phase study tests two ultra-high-dose radiation schedules (5 sessions or 1 session) in 31 men with intermediate-risk prostate cancer. The goal is to see if these intense, precise treatments are safe and can control the cancer. Participants will be followed for at least 5 years to monitor side effects and PSA levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center - Moses Campus
The Bronx, New York, 10467-2490, United States
Conditions
Explore the condition pages connected to this study.